Collaboration Details

Print  Close


Title of Collaborative Activity:

The Critical Path Institute (C-Path) International Neonatal Consortia (INC)

Description of Collaborative Activity:

The International Neonatal Consortium (INC) is a coalition of industry, academia, patient representatives, the FDA, the European Medicines Agency (EMA), other governmental agencies, professional organizations, foundations, and the Critical Path Institute (C-Path) that will focus on accelerating the development of safe and effective treatments for neonates.

Type of Collaborative Activity:

Committee, Advisory Group, or Work Group

Year the Collaborative Activity Originated:

2015

NIH Participating Institutes/Centers/Office of the Director:

NHLBI, NICHD

HHS Agency Collaborators on this Activity:

FDA